Opioid substitution and HIV/AIDS treatment and prevention
- 1 November 2004
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 364 (9449) , 1918-1919
- https://doi.org/10.1016/s0140-6736(04)17490-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The Global Fund to Fight AIDS, Tuberculosis and Malaria: funding for unpopular public-health programmesThe Lancet, 2004
- Expanding access to HIV antiretroviral therapy among marginalized populations in the developed worldAIDS, 2003
- Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmesAIDS, 2001
- A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid DependenceNew England Journal of Medicine, 2000
- Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan AfricaThe Lancet, 2000
- A Risk-Benefit Analysis of Methadone Maintenance TreatmentDrug Safety, 2000
- Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatmentAIDS, 2000
- Effective Medical Treatment of Opiate AddictionJAMA, 1998
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Methadone Maintenance and Addicts' Risk of Fatal Heroin OverdoseSubstance Use & Misuse, 1996